Profile data is unavailable for this security.
About the company
Circa Group AS is a Norway-based renewable chemicals company. The Company converts biomass into advanced bio-based chemicals using its proprietary Furacell process. The product portfolio is under development, and includes flavorings, biopolymers and bio-solvents such as Cyrene, an alternative to traditional polar aprotic solvents, which is produced in one step from platform biomolecule levoglucosenone. Cyrene, derived from Levoglucosenone (LGO), is greener, safer and often performs better than traditional toxic solvents used in paints, coatings, battery and textile applications as well as many more industrial processes. Circa Group AS has several subsidiaries, including Circa Sustainable Chemicals Pty Ltd, Circa Sustainable Chemicals SAS, Circa Sustainable Chemicals BV and Circa Group Pty. Ltd.
- Revenue in NOK (TTM)18.68m
- Net income in NOK-71.67m
- Incorporated2020
- Employees17.00
- LocationCirca Group ASKarenslyst alle 53OSLO 0279NorwayNOR
- Phone+47 22512020
- Websitehttps://circa-group.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alzinova AB | 269.18k | -16.43m | 107.02m | 5.00 | -- | 0.6268 | -- | 397.58 | -0.3385 | -0.3385 | 0.0055 | 2.07 | 0.0023 | -- | 0.3671 | 54,000.00 | -14.04 | -10.77 | -14.91 | -11.27 | 7,360.92 | -- | -6,103.69 | -18,447.90 | -- | -- | 0.007 | -- | -- | -- | -25.92 | -- | 15.81 | -- |
NextCell Pharma AB | 12.41m | -39.25m | 109.05m | -- | -- | 1.18 | -- | 8.79 | -0.9046 | -0.9046 | 0.286 | 1.28 | 0.1406 | 14.06 | 7.20 | -- | -44.45 | -34.92 | -50.09 | -37.06 | 12.04 | -68.21 | -316.25 | -538.60 | 4.36 | -- | 0.00 | -- | 80.96 | 72.85 | -15.21 | -- | -- | -- |
Odi Pharma AB (publ) | 815.90k | -3.96m | 110.01m | -- | -- | 54.19 | -- | 134.83 | -0.2608 | -0.2608 | 0.0538 | 0.1338 | 0.1084 | 1.22 | 6.98 | -- | -52.58 | -- | -95.24 | -- | -53.07 | -- | -484.96 | -- | 1.32 | -14.10 | 0.00 | -- | -55.44 | -- | 4.67 | -- | -- | -- |
Bioextrax AB publ | 1.62m | -22.09m | 110.26m | -- | -- | 6.04 | -- | 67.93 | -0.8034 | -0.8034 | 0.0588 | 0.5315 | 0.0686 | -- | 4.96 | -- | -93.29 | -86.39 | -102.02 | -110.84 | 3.62 | -- | -1,360.93 | -2,119.90 | -- | -- | 0.00 | -- | 420.51 | 24.40 | -15.21 | -- | 56.86 | -- |
New Nordic Healthbrands AB | 536.18m | -10.14m | 113.03m | 70.00 | -- | 1.09 | -- | 0.2108 | -1.64 | -1.64 | 86.81 | 16.86 | 2.16 | 1.84 | 4.96 | 7,367,219.00 | -4.09 | 5.36 | -9.16 | 10.55 | 65.32 | 67.30 | -1.89 | 2.38 | 0.8584 | -4.44 | 0.2821 | 47.96 | 9.51 | 6.28 | -119.41 | -- | 28.36 | -- |
Coegin Pharma AB | 0.00 | -27.89m | 113.58m | 0.00 | -- | 8.75 | -- | -- | -2.65 | -2.65 | 0.00 | 0.6403 | 0.00 | -- | -- | -- | -125.24 | -122.02 | -201.53 | -154.70 | -- | -- | -- | -28,466.75 | -- | -170.65 | 0.00 | -- | -- | -- | 20.60 | -- | -- | -- |
Isofol Medical AB (publ) | 0.00 | -31.06m | 115.46m | 4.00 | -- | 1.03 | -- | -- | -0.1964 | -0.1964 | 0.00 | 0.6993 | 0.00 | -- | -- | 0.00 | -20.49 | -66.73 | -24.10 | -88.27 | -- | -- | -- | -1,023.62 | -- | -- | 0.00 | -- | -94.37 | -- | 76.80 | -- | -- | -- |
StenoCare A/S | 6.27m | -25.66m | 124.61m | 9.00 | -- | 3.64 | -- | 19.89 | -1.13 | -1.13 | 0.2674 | 1.22 | 0.1285 | -- | 2.94 | -- | -52.62 | -28.16 | -70.34 | -35.47 | -- | -- | -409.55 | -371.06 | 1.04 | -5.56 | 0.2362 | -- | -16.30 | -- | -7.77 | -- | -- | -- |
Enorama Pharma AB | 667.97k | -42.34m | 128.34m | 5.00 | -- | 5.46 | -- | 192.13 | -1.03 | -1.03 | 0.0163 | 0.4271 | 0.0184 | 0.7583 | 0.6384 | 134,000.00 | -116.48 | -73.56 | -184.45 | -104.85 | -635.07 | 43.36 | -6,338.66 | -557.42 | 0.4626 | -605.70 | 0.02 | -- | -80.17 | -23.71 | -6.15 | -- | -- | -- |
Circa Group AS | 18.68m | -71.67m | 135.97m | 17.00 | -- | 0.3977 | -- | 7.28 | -0.6578 | -0.6578 | 0.1689 | 2.80 | 0.0403 | 5.46 | 0.9139 | 1,098,678.00 | -15.46 | -- | -19.96 | -- | 75.64 | -- | -383.72 | -- | 0.7097 | -- | 0.00 | -- | 41.73 | -- | -0.0491 | -- | -- | -- |
Toleranzia AB | 0.00 | -6.28m | 137.53m | 7.00 | -- | 0.9032 | -- | -- | -0.0405 | -0.0405 | 0.00 | 0.775 | 0.00 | -- | -- | 0.00 | -4.50 | -7.45 | -4.65 | -7.78 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 11.79 | -- | 63.90 | -- |
PMD Device Solutions AB | 28.54m | -36.07m | 139.26m | 1.00 | -- | -- | -- | 4.88 | -16.69 | -16.69 | 6.34 | -4.79 | 0.9465 | -- | 57.42 | -- | -119.63 | -- | -- | -- | 58.18 | -- | -126.39 | -- | 0.0505 | -3.00 | -- | -- | -- | -- | -- | -- | -- | -- |
Bactiquant A/S | 18.78m | -20.00m | 143.49m | -- | -- | 6.52 | -- | 7.64 | -0.6358 | -0.6358 | 0.5971 | 0.6133 | 0.5055 | 3.67 | 2.83 | -- | -53.83 | -41.26 | -62.59 | -47.16 | -6.14 | 12.89 | -106.51 | -71.77 | 5.43 | -8.54 | 0.0431 | -- | -0.689 | -- | 7.62 | -- | -- | -- |
Lipum AB (publ) | 0.00 | -37.07m | 144.86m | 5.00 | -- | 14.50 | -- | -- | -4.38 | -4.38 | 0.00 | 0.4726 | 0.00 | -- | -- | 0.00 | -159.35 | -127.85 | -206.31 | -184.50 | -- | -- | -- | -293,228.70 | -- | -- | 0.2781 | -- | -- | -- | 2.38 | -- | -- | -- |
Xintela AB | 375.86k | -49.09m | 152.06m | -- | -- | -- | -- | 404.57 | -0.1217 | -0.1217 | 0.0008 | -0.0136 | 0.0193 | -- | 0.0447 | -- | -252.59 | -181.06 | -- | -391.61 | 100.00 | -- | -13,061.54 | -235,894.00 | -- | -49.47 | -- | -- | -- | -45.54 | 18.32 | -- | -61.47 | -- |
Vo2 Cap Holding AB (publ) | 341.77m | 3.20m | 154.09m | 103.00 | 47.64 | 0.699 | 3.03 | 0.4509 | 0.0607 | 0.0607 | 6.50 | 4.13 | 0.7493 | -- | 7.03 | 3,328,282.00 | 0.7023 | -0.2564 | 0.9347 | -0.3839 | 34.62 | 23.36 | 0.9373 | -0.2409 | -- | 1.18 | 0.1564 | -- | -26.09 | 85.65 | -57.92 | -- | -17.96 | -- |
Holder | Shares | % Held |
---|---|---|
Storebrand Asset Management ASas of 01 Sep 2022 | 2.34m | 1.92% |
Robeco Schweiz AGas of 29 Mar 2024 | 2.20m | 1.80% |
First Fondene ASas of 01 Sep 2022 | 2.11m | 1.73% |
Fj�rde AP-fondenas of 01 Sep 2022 | 1.53m | 1.25% |
Goldman Sachs Asset Management LPas of 29 Feb 2024 | 941.10k | 0.77% |
Forte Fondsforvaltning ASas of 30 Apr 2024 | 125.00k | 0.10% |